Skip to content
About
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
View all Diseases
Topics
Diagnostics
Biology
Trial Updates
Treatment
Surgery
Prevention
View all Topics
Conferences
ACTRIMS Forum 2021
CONy 2020
MDS 2020
AAIC 2020
FENS 2020
EAN 2020
View all Conferences
Features
About
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Search
Prevention
2:45
Using AI to predict epileptic seizures
Daniel Goldenholz
• 26 Oct 2020
2:16
MS: challenges and the impact of a healthy lifestyle
Abhijit Chaudhuri
• 21 Oct 2020
3:34
Gene-environment interactions in Huntington’s disease
Anthony Hannan
• 20 Jul 2020
1:48
Gene-environment interactions and neurodegeneration
Tara Spires-Jones
• 16 Jul 2020
11:31
Therapeutic landscape for cluster headache
Stewart Tepper
• 24 May 2020
2:09
Challenges in migraine management
Uwe Reuter
• 22 May 2020
20:54
CGRP monoclonal antibodies & migraine management during COVID-19 pandemic
Stewart Tepper
• 24 May 2020
19:11
Benefit of migraine prevention with erenumab
Stewart Tepper
• 24 May 2020
3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter
• 22 May 2020
2:44
PROMISE-1: eptinezumab in episodic migraine
Messoud Ashina
• 29 May 2020
2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter
• 22 May 2020
2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter
• 22 May 2020
1:30
Migraine: CGRP mAbs efficacy measured over time
Dagny Holle-Lee
• 20 May 2020
3:29
The evolving migraine prevention landscape: EAN 2020 highlights
Messoud Ashina
• 29 May 2020
2:33
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures
Uwe Reuter
• 22 May 2020
3:16
PEARL study: fremanezumab for chronic or episodic migraine in the real world
Messoud Ashina
• 29 May 2020
1
2
Next
